GOLD A/ B から GOLD E への進行: COPD の患者が新たに吸入療法を開始した際の主張分析
Trishul Siddharthan1, Sanjay Sethi2, Emily Wan3,4
1Miller School of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Miami, FL, Miami, USA. tsiddhar@miami.edu.
BMC pulmonary medicine
|August 30, 2025
まとめ
慢性閉塞性肺疾患 (COPD) の患者のほとんどは,吸入治療にもかかわらず,重症化に至った. 中程度の悪化歴は,疾患の進行のリスクを大幅に増加させた.
科学分野:
- 肺科
- 呼吸器医学
- 臨床流行病学
背景:
- 慢性閉塞性肺疾患 (COPD) は,著しい罹病率と死亡率を持つ進行性呼吸器疾患である.
- 急性悪化はCOPDの重荷と疾患の進行に大きく寄与しています
研究 の 目的:
- 慢性阻害性肺疾患 (GOLD) A/ B0またはA/ B1に分類された慢性阻害性肺疾患 (COPD) の患者の進行を評価する.
- GOLD Eフェノタイプへの進行の予測要因を特定し,頻繁または重度の悪化によって定義する.
主な方法:
- Optum Clinformatics® Data Martデータベースを使用した遡及的観察コホート研究.
- 2016年1月から2023年6月までの間,COPDを新たに開始した患者
- カプラン・メイヤー法では,GOLD Eへの進行率を推定し,多変量コックス比例危険モデルで予測値を分析した.
主要な成果:
- 156,462人の患者の大半は5年以内にGOLD Eに進行した.
- GOLD A/ B0の患者と比べて,前回の中度悪化 (GOLD A/ B1) の患者は,GOLD Eへの進行のリスクがほぼ3倍であった.
- 中程度の悪化歴,高齢化,メディケア保険,併発症は進行を予測する重要な要因でした.
結論:
- COPDのインハラメンテナンス療法を受けているほとんどの患者は,頻繁または重度のエクスサバター型に進行する.
- 現在の治療法では,COPDの病状を変化させるには不十分かもしれません.
- COPDの進行を修正するための新しい治療戦略が不可欠です.
関連する概念動画
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:26COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:20COPD: Pathogenesis and Clinical Features
516
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K